Hepion Pharmaceuticals Inc (NASDAQ: HEPA): The Best-Of-Breed For Investing?
Currently, there are 10.62M common shares owned by the public and among those 10.57M shares have been available to trade. Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, […]
